Rethinking Science, Policy
Public Funding, Patents, and Technology Transfer: Learning from the Contrasting Oxford and Texas Models of COVID-19 Vaccine Production and Distribution
About the Seminar
April 29, 2024 9:00am—10:00am
The COVID-19 pandemic spurred substantial debate over how to rapidly develop new vaccines, produce billions of doses, and distribute them globally. Central to these debates are the roles of intellectual property, technology transfer, and public funding. Ken Shadlen explored these issues, drawing on the global production experiences of two publicly-funded vaccines developed in university labs: one from the University of Oxford in the UK, and the other from Baylor College of Medicine in the US. The presentation examined how the innovation ecosystem functioned during the COVID-19 pandemic and offered insights for policymakers preparing for future pandemics and other global challenges.
Links
Past Series
-
November 18, 2025 9:00am
Rethinking Measuring and Communicating Societal Impacts
Susanna Campbell
-
October 08, 2025 9:00am
Rethinking the Outcomes of University Research
David Guston
-
September 24, 2025 9:00am
Rethinking the Outcomes of Biomedical Research
Jeffrey Alexander
-
May 20, 2025 9:00am
Rethinking the NIH: Indirect Cost Recovery Policy
Bhaven N. Sampat
-
March 31, 2025 9:00am
Rethinking Taste and Odor in Drinking Water: From Obstacle to Opportunity
Christy Spackman, Susheera Pochiraju
-
March 20, 2025 9:00am
Rethinking Technology Assessment: Policy Signal vs. Noise
John Alic
-
April 24, 2025 9:00am
Rethinking Containment: Deliberately Released Genetically Engineered Organisms
Emma Frow, Dalton George
-
October 03, 2024 3:30pm
Carbon Removal Social [Science]
Holly Buck, Sara Nawaz, Rory Jacobson, Marcela Mulholland, Amanda Borth
-
June 04, 2024 12:00pm
Hopeful Climate Futures through Speculative Storytelling: Decolonizing Global Climate Action
Chinelo Onwualu, Joey Eschrich
